期刊文献+

VEGF-C及其受体Flt-4与乳腺癌淋巴途径转移的相关性 被引量:1

Relationship of VEGF-C/Flt-4 expression to lymph metastasis in breast carcinoma
下载PDF
导出
摘要 [目的]探讨VEGF-C/Flt-4系统在乳腺癌淋巴途径转移中的作用和意义,[方法]采用免疫组织化学方法检测61例乳腺癌癌细胞的VEGF-C和Flt-4的表达,在乳腺癌期间质淋巴管上皮及Flt-4的表达情况。[结果]乳腺癌61例,VEGF-C表达阳性率为80.32%(49/61),Flt-4表达阳性率为73.77%(45/61),并且Flt-4阳性指数随VEGF-C表达的增强而增强,r=0.531,P<0.01。VEGF-C阳性指数在转移组(74.04±12.11)明显高于未转移组(55.88±13.56),P<0.01;随着癌细胞VEGF-C表达强度的增强,Flt-4阳性脉管数也随之增多,各组间均有显著差异,P<0.01。乳腺癌中Flt-4阳性脉管数在淋巴结转移(11.37±3.80)明显高于未转移组(4.64±3.84),P<0.01。VEGF-C/Flt-4的表达与肿瘤的大小、病人的年龄以及肿瘤的雌孕激素受体的表达无关;与肿瘤细胞C-erbB-2的表达及P53蛋白的表达有关。[结论]人乳腺癌细胞VEGF-C及其受体Flt-4的表达与淋巴结转移呈正相关。Flt-4阳性淋巴管数可指示乳腺癌淋巴转移。 [ Objective] To identify the function of VEGF - C/FIt - 4 system in metastasis of primary breast cancer and its climical significance. [ Methods] A series of 61 primary breast carcinomas were detected for the expressions of VEGF - C, Flt- 4 by immunohistochemical method. Expression of Flt- 4 in lymph vessels, and relationship of the expression of VEGF - C/FIt - 4 system to lymph metastasis of breast cancer were analyzed, Furtheremore, the relationship of the expression of VEGF - C/FIt - 4 system of carcinoma cells to the number of lymph vessels, and the relationship of the number of Flt- 4 positive vessels to lymph node metastasis were also studied. [Results] The positive rate of VEGF - C and wene Fit - 4 in the pnea at carcinomas 88.52 % (53/61), and the positive rate of Flt-4 was 8.97 % (50/61). With the increase of the expression of VEGF - C, the positive index of Flt - 4 was increasing ( r = 0.531, P 〈 0.01). The positive index of VEGF - C in lymph node metastasis group(70.04 ± 12.11 )was significantly higher than that of no lymph node metastasis group (55.88 ± 13.56)( P 〈 0.01 ). With the increase of VEGF- C protein level, the number of Flt- 4 positive vessels was increaseing (P 〈 0.01 ). The number of Flt- 4 positive vessels in lymph node metastasis group (12.37 ±3.80 ) was significantly higher than that in no lymph node metastasis group (6.64± 3.84 ) ( P 〈 0.01 ). The expression of VEGF - C/FIt - 4 was not releated to the size of the tumor, the expression of the ER and PR and its clinical states,but were releated to the expression of C- erbB- 2 and P53. [ Conclusion] The overexpressious of VEGF - C and Flt- 4 in primary breast carcinoma related to lymph node metastasis and VEGF - C/FIt - 4 system can promote vasculogenesis. The number of Flt- 4 positive vessels is closely related to lymph node metastasis in the breast carcinoma.
作者 宋尉官 胡祥
出处 《大连医科大学学报》 CAS 2005年第6期413-417,共5页 Journal of Dalian Medical University
关键词 血管内皮细胞生长因子-C 乳腺癌 肿瘤转移 FLT-4 淋巴途径 vascular endothelial growth factor (VEGF) breast carcinoma lymphatic metastasis
  • 相关文献

参考文献8

  • 1Kitamura K, Yamaguchi T, Taniguchi H, et al. Analysis of lymph node metastasis in early gastric cancer : rationale of imitated surgery[J]. Surg Onclo,1997,64(1):42-49.
  • 2Kaipainen A, Korhoren J, Taipale J, et al. Expression of the fms-like tyrosine kinase FLT-4 gene becomes restricted to endothelium of lymphaticvessels during development[J]. Proc Natl Acad Sci USA, 1995,92(8):3566-3570.
  • 3Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor , VEGF-C,is a ligand for the Flt-4(VEGFR-3) and KDR(VEGFR2) recepter tyrosine kinases [J]. ENBO J,1996,15(2):290-298.
  • 4Koolwijk P, Peters E, Vander V, et al. Involvement of VEGFR-2(kdr/flk-1) but not VEGFR-1(flt-1) in VEGF-A and VEGF-C induced tube information by human microvascular endothelial cells in fibrin matrices in vitro[J].Angiogenesis,2001,4(1):53-60.
  • 5Dumont DJ, Jussila L, Taipale J, et al.Cardiovascular failure in mouse embryos deficient in VEGF receptor 3[J].Science,1998,282(5390):946-949.
  • 6Mandtiota SJ, Jussila L, Jeltsch M, et al. Vascular dndothelial growth factor-C-mediated lymphagiogenesis promotes tumour metastasis[J].EMOB J,2001,20(4):672-682.
  • 7Yonemura Y, Fuahida S, Bando E, et al. Lyphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 [J].Eur J Cancer, 2001,37(7):918-923.
  • 8Yang Q, Yoshimura G, Suzuma T, et al.Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma[J].Clin Cancer Res,2001,7(12):3867-3873.

同被引文献30

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部